Norris Medicines Ltd. - Research Center
524414 NORRIS Group (XT) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Jun' 24 |
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Sales |
0.72 |
1.49 |
0.65 |
2.56 |
0.95 |
Operating profit |
-0.16 |
0.49 |
-0.04 |
-0.25 |
-0.39 |
Interest |
0.08 |
0.11 |
0.09 |
0.09 |
0.09 |
Gross profit |
-0.23 |
0.40 |
-0.13 |
-0.33 |
-0.47 |
EPS (Rs) |
-0.37 |
0.18 |
-0.27 |
-0.48 |
-0.62 |
Quarterly
results in details
|
Jun' 24 |
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Other income |
0.01 |
0.03 |
- |
- |
- |
Stock adjustment |
-0.38 |
-0.40 |
-0.07 |
0.74 |
-0.77 |
Raw material |
0.55 |
0.62 |
0.13 |
1.28 |
1.13 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.34 |
0.41 |
0.34 |
0.48 |
0.60 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
0.37 |
0.37 |
0.29 |
0.30 |
0.37 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.13 |
0.14 |
0.14 |
0.14 |
0.14 |
Taxation |
- |
0.09 |
- |
- |
- |
Net profit / loss |
-0.37 |
0.17 |
-0.27 |
-0.48 |
-0.61 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
9.93 |
9.93 |
9.93 |
9.93 |
9.93 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
-22.28 |
32.63 |
-6.13 |
-9.60 |
-40.74 |
GPM (%) |
-31.83 |
26.54 |
- |
- |
- |
NPM (%) |
-49.72 |
11.53 |
- |
- |
- |